ONO-4538 Phase I Study in Patients With Solid Tumor
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to investigate the pharmacokinetics of ONO-4538 administered to
Korean patients with advanced or recurrent solid tumors who are refractory or intolerant to
standard therapy or for whom no appropriate treatment is available.